Suppr超能文献

超声检查发现的胆囊异常与川崎病中静脉注射免疫球蛋白抵抗相关。

Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.

作者信息

Chen Chih-Jen, Huang Fu-Chen, Tiao Mao-Meng, Huang Ying-Hsien, Lin Li-Yan, Yu Hong-Ren, Yang Kuender D, Huang Yi-Chuan, Chen Chih-Cheng, Chang Wei-Chiao, Kuo Ho-Chang

机构信息

Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

ScientificWorldJournal. 2012;2012:485758. doi: 10.1100/2012/485758. Epub 2012 Jun 18.

Abstract

OBJECTIVE

Kawasaki disease (KD) is an acute systematic vasculitis in children which causes coronary arterial lesions and hydrops of gallbladder. Our objective is to correlate the clinical significance and influence on disease outcome of patients with gallbladder abnormalities in Kawasaki dissease.

METHODS

Children who met KD diagnosis criteria and were admitted for IVIG treatment were retrospectively enrolled for analysis. Patients with abdominal sonography were divided into 2 groups based on the absence (Group A, N = 61) or presence (Group B, N = 16) of gallbladder abnormalities (GBA), defined as hydrops or acalculous cholecystitis. Between the two groups, clinical features, demographic data (including admission days, coronary artery lesions, IVIG resistance), and laboratory data before/after IVIG treatment were collected for analysis.

RESULTS

The presence of sonographic gallbladder abnormalities is correlated with higher levels of serum CRP, GPT, and neutrophils. It also points to an increased number of IVIG resistance rates in group B. There was no significant statistical difference among clinical features, age, gender, admission days, or coronary artery lesions between the two groups.

CONCLUSION

Sonographic gallbladder abnormalities are associated with higher CRP, GPT, neutrophil and IVIG resistance in KD. It can be used as a predictor of IVIG resistance in patients with KD.

摘要

目的

川崎病(KD)是一种儿童急性全身性血管炎,可导致冠状动脉病变和胆囊积液。我们的目的是探讨川崎病患者胆囊异常的临床意义及其对疾病预后的影响。

方法

回顾性纳入符合KD诊断标准并接受静脉注射免疫球蛋白(IVIG)治疗的儿童进行分析。根据腹部超声检查结果,将患者分为两组:无胆囊异常组(A组,N = 61)和有胆囊异常组(B组,N = 16),胆囊异常定义为胆囊积液或非结石性胆囊炎。收集两组患者的临床特征、人口统计学数据(包括住院天数、冠状动脉病变、IVIG抵抗)以及IVIG治疗前后的实验室数据进行分析。

结果

超声检查发现胆囊异常与血清CRP、GPT和中性粒细胞水平升高相关。这也表明B组中IVIG抵抗率增加。两组在临床特征、年龄、性别、住院天数或冠状动脉病变方面无显著统计学差异。

结论

超声检查发现的胆囊异常与KD患者较高的CRP、GPT、中性粒细胞水平及IVIG抵抗相关。它可作为KD患者IVIG抵抗的预测指标。

相似文献

1
Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
ScientificWorldJournal. 2012;2012:485758. doi: 10.1100/2012/485758. Epub 2012 Jun 18.
4
Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Int J Clin Pract. 2022 Aug 3;2022:2726686. doi: 10.1155/2022/2726686. eCollection 2022.
5
Gallbladder Hydrops Associated With Kawasaki Disease: A Case Report and Literature Review.
Clin Pediatr (Phila). 2018 Mar;57(3):341-343. doi: 10.1177/0009922817696468. Epub 2017 Mar 1.
6
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603. eCollection 2015.
8
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.
9
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
World J Pediatr. 2020 Dec;16(6):607-613. doi: 10.1007/s12519-020-00348-2. Epub 2020 Mar 30.
10
Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Pediatr Neonatol. 2014 Oct;55(5):387-92. doi: 10.1016/j.pedneo.2013.11.007. Epub 2014 Mar 11.

引用本文的文献

1
Kawasaki Disease With Acute Acalculous Cholecystitis: A Case Report.
Cureus. 2023 Dec 1;15(12):e49789. doi: 10.7759/cureus.49789. eCollection 2023 Dec.
3
Coronary Artery Disease and Gallbladder Inflammatory Pseudopolyps.
Diagnostics (Basel). 2022 Jan 10;12(1):155. doi: 10.3390/diagnostics12010155.
4
6
Tight junction protein ZO-1 in Kawasaki disease.
BMC Pediatr. 2021 Mar 31;21(1):157. doi: 10.1186/s12887-021-02622-2.
7
Age-related differences in clinical characteristics of Kawasaki disease.
Braz J Med Biol Res. 2021 Jan 15;54(3):e10281. doi: 10.1590/1414-431X202010281. eCollection 2021.
8
Unusual Presentation Of Kawasaki Disease With Gastrointestinal And Renal Manifestations.
Ther Clin Risk Manag. 2019 Dec 5;15:1411-1416. doi: 10.2147/TCRM.S226624. eCollection 2019.
9
Kawasaki Disease Presenting as Acute Acalculous Cholecystitis.
Clin Pract Cases Emerg Med. 2019 Oct 14;3(4):383-386. doi: 10.5811/cpcem.2019.8.44255. eCollection 2019 Nov.
10
Acute acalculous cholecystitis in children.
World J Gastroenterol. 2018 Nov 21;24(43):4870-4879. doi: 10.3748/wjg.v24.i43.4870.

本文引用的文献

1
Kawasaki disease: an update on diagnosis and treatment.
Pediatr Neonatol. 2012 Feb;53(1):4-11. doi: 10.1016/j.pedneo.2011.11.003. Epub 2012 Jan 17.
2
Genetic polymorphisms in Kawasaki disease.
Acta Pharmacol Sin. 2011 Oct;32(10):1193-8. doi: 10.1038/aps.2011.93. Epub 2011 Sep 5.
3
Septic shock and hypofibrinogenemia predict a fatal outcome in childhood acute acalculous cholecystitis.
J Pediatr Gastroenterol Nutr. 2011 Nov;53(5):548-52. doi: 10.1097/MPG.0b013e318230c380.
4
ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.
PLoS One. 2011 Apr 14;6(4):e17370. doi: 10.1371/journal.pone.0017370.
5
Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese children.
J Clin Immunol. 2011 Aug;31(4):650-5. doi: 10.1007/s10875-011-9524-8. Epub 2011 Apr 13.
6
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.
J Pediatr. 2011 May;158(5):831-835.e3. doi: 10.1016/j.jpeds.2010.10.031. Epub 2010 Dec 18.
7
CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.
J Clin Immunol. 2011 Apr;31(2):240-4. doi: 10.1007/s10875-010-9484-4. Epub 2010 Nov 17.
8
Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Acta Paediatr. 2010 Oct;99(10):1578-83. doi: 10.1111/j.1651-2227.2010.01875.x. Epub 2010 Jun 7.
9
Coronary artery fistula associated with Kawasaki disease.
Am Heart J. 2009 Mar;157(3):584-8. doi: 10.1016/j.ahj.2008.11.020. Epub 2009 Feb 3.
10
Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease.
J Korean Med Sci. 2008 Aug;23(4):718-22. doi: 10.3346/jkms.2008.23.4.718.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验